TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
HR or Marketing? Claim Your Free Employer Account
BE THE FIRST TO ANSWER
What is the dress code at TG Therapeutics?
0 Answers from Employees at TG Therapeutics
About Company Q&A on Comparably
Help answer questions real people are asking about your company. Your answers will be 100% anonymous.
The person asking the question will be notified of your answer, and it will be posted publicly. Your identity will be kept private
Recently Asked Questions
No Questions Available
Recently Answered Questions
No Questions Available
×